Nitric oxide and prostacyclin inhibit fetal platelet aggregation: A response similar to that observed in adults
- 1 December 1992
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 167 (6) , 1599-1604
- https://doi.org/10.1016/0002-9378(92)91748-y
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.Proceedings of the National Academy of Sciences, 1987
- ENDOGENOUS NITRIC OXIDE INHIBITS HUMAN PLATELET ADHESION TO VASCULAR ENDOTHELIUMPublished by Elsevier ,1987
- The anti‐aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxideBritish Journal of Pharmacology, 1987
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987
- Formation of prostanoids in human umbilical vessels perfusedProstaglandins, 1986
- Prostaglandin production and stimulation by angiotensin II in the isolated perfused human placental cotyledonAmerican Journal of Obstetrics and Gynecology, 1985
- Evidence for the inhibitory role of guanosine 3', 5'-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilatorsBlood, 1981
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976
- Altered Platelet Function in NewbornsPediatric Research, 1970